Spots Global Cancer Trial Database for GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
Official Title: GAMBIT Trial: A Randomized,Non-comparative, Open-label Clinical Trial Evaluating Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
Study ID: NCT01859728
Conditions
Study Description
Brief Summary: To evaluate safety and efficacy of the combination cisplatin plus irinotecan in the treatment of biliary tract cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Barretos Cancer Hospital, Barretos, SP, Brazil
Contact Details
Name: Lucas V dos Santos, MD
Affiliation: Barretos Cancer Hospital
Role: STUDY_CHAIR
Name: Kathia C Abdalla, MD
Affiliation: Barretos Cancer Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Joao Paulo S N Lima, MD, PhD
Affiliation: Barretos Cancer Hospital
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
